1
TÍTULO: Cobicistat Compared With Ritonavir as a Pharmacoenhancer for Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate: Week 144 Results
AUTORES: Joel E Gallant; Ellen Koenig; Jaime F Andrade Villanueva; Ploenchan Chetchotisakd; Edwin DeJesus; Francisco Antunes; Keikawus Arasteh; Giuliano Rizzardini; Jan Fehr; Hui C Liu; Michael E Abram; Huyen Y Cao; Javier Szwarcberg;
PUBLICAÇÃO: 2015, FONTE: JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, VOLUME: 69, NÚMERO: 3
INDEXADO EM: Scopus WOS
2
TÍTULO: Cobicistat Versus Ritonavir as a Pharmacoenhancer of Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naive HIV Type 1-Infected Patients: Week 48 Results
AUTORES: Joel E Gallant; Ellen Koenig; Jaime Andrade Villanueva; Ploenchan Chetchotisakd; Edwin DeJesus; Francisco Antunes ; Keikawus Arasteh; Graeme Moyle; Giuliano Rizzardini; Jan Fehr; Yapei P Liu; Lijie J Zhong; Christian Callebaut; Javier Szwarcberg; Martin S Rhee; Andrew K Cheng;
PUBLICAÇÃO: 2013, FONTE: JOURNAL OF INFECTIOUS DISEASES, VOLUME: 208, NÚMERO: 1
INDEXADO EM: Scopus WOS CrossRef